project id: TCGA-OV; case submitter id: TCGA-30-1862; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.4; rna integrity number: 8.6; spectrophotometer method: UV Spec; age at index: 65; days to birth: -23895; days to death: 186; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1938; year of death: 2003; age at diagnosis: 23895; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 186.0; figo stage: Stage IV; icd 10 code: C56.9; last known disease status: not reported; morphology: 8441/3; primary diagnosis: Serous cystadenocarcinoma, NOS; prior malignancy: not reported; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Ovary; synchronous malignancy: Not Reported; tissue or organ of origin: Ovary; tumor grade: Not Reported; year of diagnosis: 2003; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 124.0; composition: Not Reported; preservation method: Unknown; sample id: 6211110a-552c-492f-b066-c3b41db7fbad; sample submitter id: TCGA-30-1862-01A; portion id: 435274be-1d2a-4b64-9d4b-2bceaf700030; portion submitter id: TCGA-30-1862-01A-02; percent necrosis: 0.0; percent normal cells: 0.0;